Activity Number:
|
243
- Contributed Poster Presentations: Biopharmaceutical Section
|
Type:
|
Contributed
|
Date/Time:
|
Monday, July 31, 2017 : 2:00 PM to 3:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract #324193
|
|
Title:
|
Sample Size Re-Estimation and Other Midcourse Adjustments with Sequential Parallel Comparison Design
|
Author(s):
|
Rachel Silverman* and Anastasia Ivanova
|
Companies:
|
University of North Carolina and UNC at Chapel Hill
|
Keywords:
|
Placebo respose ;
Sequential Parallel Comparison Design ;
SPCD ;
Sample size re-estimation ;
Adaptive design
|
Abstract:
|
Sequential parallel comparison design (SPCD) was proposed to reduce placebo response in a randomized trial with placebo comparator. This design is achieved by randomizing subjects between placebo and drug in stage 1 of the trial and then re-randomizing in stage 2 of the trial those subjects who did not respond to placebo in stage 1. Efficacy analysis of the study data includes all data from stage 1 and all placebo non-responding subjects from stage 2. This investigation analyzes the possibility to increase the sample size and adjust the design parameters during an interim analysis; these design parameters include, allocation proportion to placebo in stage 1 of SPCD and weight of stage 1 data in the overall efficacy test statistic.
|
Authors who are presenting talks have a * after their name.